Itch, also referred to as pruritus, is an unpleasant cutaneous sensation provoking the desire to scratch. It is often an uncomfortable, subjective sensation responsible for decreased quality of life in a variety of psychodermatological conditions. Comorbid psychiatric conditions, including depression and anxiety, are frequently associated with itch and scratch cycle. The reciprocal and intricate relationship between the psyche and itch has been widely studied. The neurobiology of itch involves the complexity of specific mediators, itch-related neuronal pathways, and central processing of itch. The connection between itch and the psyche can be grouped under three headings: pruritic diseases with psychosocial sequelae, pruritic diseases aggravated by psychosocial factors, and psychiatric disorders causing pruritus. Itch and pain modulation go together in most circumstances and involve various substances including histamine, interleukins, proteaseactivated receptors, transient receptor potential receptors, opioids, and cannabinoids. The close interaction between keratinocytes and nerve endings modulating pain and itch also play a major role. Management of itch associated with its psychosomatic components is directed at an underlying cause and adopting a holistic approach to address not only dermatologic and somatosensory aspects, but also the cognitive, emotional, and psychosocial components. An integrated multidisciplinary team consisting of a dermatologist, psychiatrist, psychologist, and social worker is vital in addressing the multifaceted aspects of pruritus.
and drug-induced pruritus. Group III refers to chronic scratch lesions. Here, pruritus invariably leads to scratching and rubbing of the skin, leading to excoriations, crusts, lichenification, papules, and nodules. These patients have prominent scratch marks, and their pruritus has been going on for a long time, sometimes even years. IFSI further classifies pruritus on an etiologic basis in six categories. Category I is comprised of dermatological causes such as psoriasis, atopic dermatitis, xerosis, scabies, and urticaria. Category II includes systemic causes such as pruritus owing to liver disease, kidney diseases, blood diseases, and metabolic causes. Category III is comprised of pruritus arising from disorders of central or peripheral nervous system such as nerve damage, nerve compression, or nerve irritation. Category IV includes psychogenic or psychosomatic causes. Category V refers to mixed variety, since in many patients, more than one underlying disease may be responsible for itch. An example of this can be displayed in dry skin with renal disease, possibly leading to pruritus. Category VI refers to conditions where no underlying disease may be recognized and may be referred to as pruritus of unknown origin.
The psychological aspects of pruritus can be better understood by the famous itch-scratch cycle. Patients with pruritus experience the urge to scratch as an autonomic response to the sensation of itch. Their attention is focused on the itch, and this leads to increased perception of pruritus and intensification of suffering. Scratching provides intermediate relief of discomfort and may serve to reduce inner tension, in which negative reinforcement leads to conditioned scratching. Thus, the vicious cycle of itch-and-scratch develops, leading to loss of control, helplessness, despondency, and guilt. 6 The concept of somatoform dissociation in the itch process was discussed by Gupta and Gupta. 7 The translation of psychological conflicts into skin symptoms, such as pruritus, was studied in 360 patients, including 44 psychiatry outpatients and 316 nonclinical participants. The participants of this study rated the severity of nine medically unexplained cutaneous symptoms and completed the Dissociative Experience Scale. Authors concluded that itching may be a symptom of somatoform dissociated and even milder degrees of dissociation, and this nonclinical range may play a role in the prediction of unexplained, cutaneous sensory symptoms. The French Psychodermatology Group replaced the term of psychogenic pruritus with functional itch disorder. 8 The group
proposed the definition of functional itch disorder as, "an itch disorder, where itch is at the center of the symptomology and when psychological factors play an evident role in the triggering, intensity, aggravation, or persistence of the pruritus." The diagnostic criteria suggested by this group is shown in Table 1 .
Psychoanalytical model of itch
According to Freud's protective shield model, ego is rooted in the body, especially in the skin during early development. The body sensations, mother/child intimate contact, and other experiences in early childhood development are directly related to ego development around this time. Ego remains partly identified to the skin even as the person becomes an adult. The disruption of the normally integrated state of ego results in symptoms referred to the skin. 9 In addition, Anzieu's skin ego model is defined by the different senses of the body. The different layers of experienced sensations of this body ego go on to form the psychic envelope. This theory explains how early trauma owing to the failures of maternal care can continue to have an impact in adult life. 10 Bick's psychic skin theory discusses how a mother's containing functions allow a first psychic skin to develop, which then defines an infant's psychic space and affords the infant a degree of self-containment, also known as stabilization of drive forces. 11 Stern's narrative envelope gives us another way to conceptualize the development of preverbal communication. It derives from the interaction between psychoanalysis and neurosciences. 12 
Biopsychosocial model
It is well documented that psychological stress and personality traits have a strong influence on itch. Psychological factors play an important role in the development, modification, or maintenance of itching. This has led to the formation of the biopsychosocial model of itching. This model postulates that internal factors such as personality traits or external factors such as stress may lead to individual factors modulating itch at different levels. These modulating factors in turn influence the itch intensity by initiating or enhancing certain physiological responses, such as release of itch mediators or activation of mast cells, which eventually result in itching sensation or modification of and social factors along with their possible mediating role of physiological processes. 13 It was also noted that cognitive factors, such as helplessness and worrying, and the behavioral response of scratching have negative association in the production and perpetuation of itch.
P model
The 5 P model of case formulation also plays a major role in the etiology and management of itch in skin disorders characterized by itch, like many other disorders. The 5 P system is characterized by Predisposing, Precipitating, Perpetuating, Protective factors, and Presenting problems. These factors have a tremendous importance in case formulation and management process. Table 2 shows the overlapping pattern of 5 P model with biopsychosocial model. Table 2 ).
The perspective model explains how to bring together the ingredients of biopsychosocial model and turn them into integrative and rational formulation and treatment plan. Each of the four perspectives comes with a treatment paradigm 16 (see Table 3 ). The elements of the 4-perspectives model include disease, dimension, behavior, and life story.
Disease
Disease is a keystone of biomedical perspective and is a pathological state with a specific etiology with a likely prognosis. The treatment of disease involves prevention and cure by interventions, both pharmacological and psychological, that directly or indirectly affect the pathological state. With this element, the etiology of patients' symptoms is understood as arising from structural or functional pathology within a specific organ or organ system. Here, the question asked is: "What disease, if any, does this patient have?" 
Psychophysiology of pruritus
Stress is believed to augment the perception of itch by several mechanisms, such as causing hemodynamic-related changes, increasing blood flow, altering body temperature, inducing sweating promoting peripheral release of histamine, vasoactive neuropeptides, and mediators of inflammation. Psychogenic itch is mainly mediated by central nervous mechanisms through route of neuropeptides, particularly the endogenous opioids.
Depression, for example, has been associated with elevated levels of the corticotropin releasing factor, which can lead to increases in central opiate levels and amplify the perception of the itch sensation. 18 Mu opioid receptors have been implicated in the processing of itch in many studies. 19 On the contrary, Kappa opioid receptors have shown antipruritic effects as seen in TRK-820 receptor against uremic pruritus. 20 Thus it may be concluded that psychogenic pruritus is provoked by an imbalance between the mu and kappa opioid systemic pathways. 21 Psychosomatic status and psychosocial factors have been observed to be good predictors of histamine-induced itch and flare. 22 The hypothalamus-pituitary-adrenal (HPA) axis in response to stress is also shown to be impaired in patients with atopic dermatitis, causing low cortisol levels. 23 The cingulate cortex appears to be an important area in the brain involved in the processing of itch. The anterior cingulate cortex has been known to be involved in modulation of emotional and cognitive activation such as reward anticipation, and it may provide physiological basis on how mood and motivation can affect the perception and processing of itch. 24 The anticipation of development of itch alone may cause a person to scratch. For example, patients with atopic dermatitis experienced more intense itch when they were shown video recordings of other people scratching. 25 Because of this, the concept of "contagious itch" has recently been a subject of interest. The application of pruritogen-induced itch is well established. However, itch induction by a nonskin-manipulating method through the presentation of certain sounds, pictures, or videos, also known as audiovisual transmission of itch, appears to be the basis of contagious itch. The first study demonstrating that itch can be induced by visual stimuli used two separate presentations shown to an audience. The first presentation was an itch-inducing lecture showing pictures of insects, scratch marks, and allergic reactions, whereas the second presentation focused on relaxation and included pictures of baby skin or children with their mother.
The authors noted significant increase in scratching during the itch lecture as compared to relaxation lecture. 26 In another experimental study, groups of students were randomly allocated to watch one of the three videos related to cold (ice, snow, wind), pain (sporting injuries, tattoos), or itchiness (head lice, scratching). The researchers noted that all three symptoms were produced by visual cues in terms of both self-report and observed behavior in all groups. 25, 26 The role of personality and expectations for itch and scratching induced by audiovisual itch stimuli was further studied by Schut et al. 27 The authors reported agreeableness and self-consciousness were shown to be associated with induced itch and scratching in patients with chronic skin diseases, whereas neuroticism was linked to induced itch in healthy subjects. The The pairing of unconditioned stimulus, such as histamine release following an ant bite, along with an originally neutral stimulus, such as just visualizing the ant on skin, can lead to itch induction just from seeing the ant on the skin alone. In this case, the image of the ant has become a conditioned stimulus. 31 
Neuroimaging in psychogenic pruritus
In the context of the intricate relationship between skin and mind, we often feel an irresistible sensation of itch when witnessing another individual scratching. A variety of neuroimaging studies have been done to prove the role of the brain in itching.
A brain imaging study found an important functional coupling of the insula and basal ganglia in initiating the urge to scratch when provided with itch evoking visual stimuli. 32 Tey et al.
33
reported an overactive limbic system, particularly the anterior cingulate cortex, which is described as being essential in modulating emotional and cognitive activities pointing a clue to our underlying desire to itch. Coactivating of the prefrontal cortex in conjunction with the limbic system upon application of itch stimuli has been reported by Mochizuki and Yosipovitch, suggesting a regulatory interplay of this network on motivation and emotion. 34 The reward circuit, particularly in the midbrain, has been reported as a neural basis for the vicious itch-scratch cycle seen in various psychodermatoses. It appears to be linked to the development of an urge to scratch to achieve the pleasure derived from such an act. 35 
Biological mediators of itch
Molecular signaling pathways of pruritogens are described in 39 Serotonin (5HT), also involved in itch sensation, plays a relatively weaker role than the sensation of itch produced by histamine. 40 5HT evokes scratching behavior in experimental animals which is associated with activation of C fibers but not associated with faster conducting myelinated nerve fibers. 41 Based on experimental animal studies, it appears that 5HT2 receptor subtype is responsible for itch.
However, in human studies, no receptor subtype has been found for 5HT2-induced itch. 42 Acetylcholine intradermal injection evokes itch in humans as well, but like 5HT, it is less pruritogenic than histamine. Acetylcholine evokes scratching behaviors in mice, which is blocked by muscarinic M3 receptor antagonist. Patients with atopic dermatitis have more than 10-fold concentration of acetylcholine in their skin compared to normal healthy controls. 43 The enzymes associated with acetylcholine synthesis (cholineacetyltransferase) can be found in keratinocytes and skin endothelial cells. 44 Intradermal injections of leukotriene B4 (LTB4) evokes scratching behavior in mice, which was inhibited by LTB4 receptor antagonists. 45 It is not known if LTB-induced itch or scratching behavior is because of a direct effect on sensory nerve endings or secondary to other inflammatory effects, but LTB4 has been found to directly sensitize rat cutaneous C fibers. 46 In humans, the subjective response to intradermal injection of bradykinin is an intense burning pain, and itching may be experienced after the cessation of burning pain. The administration of bradykinin in the lesional skin of patients with atopic dermatitis causes less pain but a robust itch sensation. 47 Endogenous and exogenous proteases evoke itch in humans and scratching behaviors in experimental animals. Atopic dermatitis patients show upregulation in endogenous proteases in skin. 48 Proteases evoke itch through the activities of protease-activated receptors (PARs). PARs are G-protein-coupled receptors and have been named from PAR1 through 4. The role of PAR-2 in itch sensation has been widely studied. 49 Cathepsin S is another endogenous protease that can evoke itch in humans and activate PAR-2 and PAR-4. Tables 2 and 4 ).
The interaction between psych and itch can be discussed under three groups: (i) Pruritic diseases with psychiatric sequelae, (ii) Pruritic diseases aggravated by psychosocial factors, and (iii) Psychiatric diseases causing pruritus.
Pruritic diseases with psychiatric sequelae
This group may include chronic pruritic skin diseases, such as atopic dermatitis or psoriasis, various systemic diseases with pruritus including metabolic, endocrine, and infectious disorders, malignancies, and drug-induced itch. Various neurological disorders of central and peripheral nervous systems also fall into this category (Table 5 ). Itch associated with these disorders has a profound effect on the overall well-being and quality of life of these patients. Anxiety and depression are commonly seen with these patients. Patients with idiopathic generalized pruritus have been found to have more depressive and anxiety symptoms as compared to controls. 64 Patients with atopic dermatitis have shown higher levels of depression, anxiety, and suicidal ideations. 65 Itching in 67 The authors studied the sample of 109 dermatology inpatients with symptoms of pruritus. They found that 70% of the sample had up to six psychiatric diagnoses, and psychiatric or psychotherapy treatment was indicated in 62% of all patients. The negative impact of itch in various skin diseases on a patient's psychology and quality of life has been demonstrated in numerous studies. In patients with atopic dermatitis, itch intensity correlates negatively with sleep, quality of life, and coping behavior. 68, 69 The itch in psoriasis is well documented. The intensity of pruritus is correlated with a lower quality of life, feeling of stigmatization, stress, and depressive symptoms. Pruritus in psoriasis affects mood in 60%, sleep in 35%, sexual desire in 21%, and appetite in 11% [70] [71] [72] Pruritic conditions aggravated by psychosocial factors Many pruritic conditions are known to be aggravated by psychosocial factors and worsened with stress or emotional triggers. These disorders include chronic urticaria, atopic dermatitis, psoriasis, acne, hyperhidrosis, and anogenital pruritus (Table 6 ). In general, these disorders have multifactorial origins, and they themselves result in significant psychosocial stress and consequences. There is increasing evidence that emotional factors play a significant role in the development and course of many chronic skin conditions. These emotional stressors profoundly influence immunological functions. The level of social support and how these patients cope with disease play an additional role in the severity and course of chronic skin diseases. 73 No specific personality type has been demonstrated in patients with skin diseases. Certain personality traits have been suggested to be associated with the development or exacerbation of skin disorders. It is hypothesized that a distinctive personality structure based on a person's genetic predisposition or individual learning experiences may be associated with a specific biochemical setup in the brain. In regulating the migration and activity of various immune cells, this individual biochemical setup of neurotransmitters and neuropeptides may render an organism more or less susceptible to allergic inflammatory processes. 74 King and Wilson 75 used a diary technique to assess emotional state and symptom severity. They demonstrated a significant positive relationship between interpersonal stress on a given day and skin condition 24 hours later.
Personality Systems Interaction theory (PSI) was developed by Julius. 76 According to this theory, there are four interacting subsystems that structure a personality: the purpose memory (reason), the extension memory (self), the intuitive behavior control, and the object recognition system (mistake focus). The interactions between these systems are decisive for the behavioral patterns of a person and are regulated by emotional impulses. This includes the inner makeup of a person (personal)
as well as their interactions with the environment (system) and the interplay between both levels (interaction). The focus is on the personal management of feelings and the control of one's own behavior or self-control in social contexts. The benefit of PSI theory is the emphasis on identifying personal imbalances or coping mechanisms to deal with chronic skin conditions with According to these results, authors conclude that psoriasis seems to carry a higher risk of developing psychiatric comorbidity and thus needs more focus on self-motivation for prevention of addictive behavior and strengthening of self-efficacy. Anxiety and depression have been commonly associated with chronic pruritic skin conditions. They are both aggravating factors as well as consequences of itching and scratching that reinforce a vicious cycle. The perceptions of pruritus and disease severity are directly affected by depression and anxiety seen in conditions like atopic dermatitis and psoriasis. 78 The illness cognition and coping mechanisms are severely influenced by concomitant anxiety and depression symptoms in chronic pruritic skin conditions. This in turn affects disease and treatment outcomes. In chronic pruritic dermatoses, patients with negative affect have shown dysfunctional illness representation and coping behavior such as helplessness, worries, and guilt affecting the disease course and treatment outcomes. 79, 80 Various epidemiological studies have demonstrated the association of psychological stress with the presence and severity of pruritus. 81, 82 Stress as an exacerbating factor in psoriasis has been reported in multiple studies. Direct association between itch and stress has been well documented. 83, 84 The mechanism by which stress induces itch or intensify itch sensations has been reported in many studies. The suppression of HPA axis, release of itch mediators such as endogenous opioids in central nervous system, and the involvement of autonomic nervous system and its neurotransmitter acetylcholine, all have been implicated in itch associated with stress. Tran et al. 85 reported an overactive sympathetic response to itch and scratching in patients with atopic dermatitis. They also noted persistently elevated parasympathetic tone in those patients, representing a lack of adoptability in response to stress. Kim et al. 86 investigated stress-induced itch by using functional magnetic resonance imaging (fMRI). The hippocampus and subcortical structures were found to be involved in stress-associated pruritus. The authors also found that sedating antihistamines were involved in the deactivation of brain regions associated with the relief of itch by active scratching, suggesting that sedating antihistamine may decrease pruritus by promoting patterns of brain activity similar to those induced by scratching behavior.
Social support can protect people in crisis from a wide variety of pathological states. Social support can be defined as information leading the subject to believe that he is cared for and loved with member of a network of mutual obligations. 87 A strong negative correlation between social support and the presence and severity of itch was observed in another population-based study from Norway. 82 A person's ability to cope in a stressful situation is known as self-efficacy. In many pruritic skin conditions, low self-efficacy has been noted. 88 Numerous studies have demonstrated the role of a poor support system exacerbating itch and itchy dermatoses. Kretzmer et al. 89 investigated idiopathic pruritus in psychiatric inpatients.
They found the association between pruritus and inadequacy of social support and unemployment. Poor social support has been shown to be a predictor of psychological distress in patients to atopic dermatitis and psoriasis. 90 Pruritus associated with advancing age has been related with to the consequences of social isolation, loss of bonding relations, and the feeling of emptiness, along with other physiological contributors.
Psychogenic disorders causing pruritus
Patients with these conditions often lack insight into their condition. Their itch symptoms respond minimally or poorly to traditional dermatologic antipruritic agents. Their itch episodes fluctuate with varying duration of symptom-free intervals inbetween itch episodes. Interestingly, during sleep, their symptoms disappear. Many patients also feel pleasure from scratching followed by feelings of satisfaction. Psychogenic disorders causing pruritus are described in Table 7 .
Idiopathic pruritus was found in 36-42% of psychiatric inpatients, and these patients, also showed anger traits, angry temperament, and ruminative catastrophization. Under this category, somatic symptom disorder is closely associated with psychogenic pruritus. The diagnostic criteria is significant for very distressing or functionally disruptive symptoms for greater than 6 months duration 94 (Table 8 ).
It is postulated that patients with psychosomatic disorders convert overwhelming internal psychiatric conflicts to more acceptable external physical symptoms, which can then manifest as itching. 95 Dissociation is the disturbance of mental 
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Dermatitis artefacta
Dermatitis artefacta (DA) or factitious disorder, is now classified as a subtype under somatic symptoms and related disorder in DSM-V. In this condition, patients purposefully and discretely create skin lesions to fulfill an internal psychological need to satisfy a desire to be taken care of. 97 The lesions of DA are characterized by bizarre, sharply demarcated and delineated margins with geometric borders. The lesion is prevalent on the areas which are easily accessible by dominant hand. A retrospective study of 57 patients with DA found 37% of patients complained of itching. 98 Patients with DA have associated psychiatric comorbidity including borderline personality disorder, depression, eating disorder, dissociation disorder, and anxiety.
97,99
Excoriation disorder (skin picking)
Excoriation disorder has now recently been added and classified in DSM-V under the group of obsessive compulsive and related disorders. The diagnostic criterion is summarized in Table 9 . The estimated prevalence of skin picking in general population is 2-4% and 2% in dermatology outpatients. 100 The picking usually starts as a localized area of pruritus and then spreads to different parts of the body. 101 Skin picking lesions are comprised of weeping, crusting, and scarred lesions with post inflammatory hypo and hyperpigmentation. Continuous scratching of a particular part may lead to a lichen simplex chronicus picture. 102 Psychiatric comorbidities associated with skin picking include depression, anxiety, obsessive compulsive disorder, dysthymia, and social phobia. 103 
Prurigo nodularis
Prurigo nodularis occurring in patients with chronic pruritus is due to continuous scratching over a long period of time. It can emerge as the symptom of various dermatological, neurological, psychiatric, and systemic diseases or can transpire independently of a pre-existing skin disease. 104 PN may be associated with higher psychiatric comorbidity, such as anxiety and depression, compared to healthy controls. 105 A case-control study from Germany reported comparable comorbidity rates in psoriasis patients. 106 PN has been treated with calcineurin inhibitors, a Disproportionate and persistent thoughts about the seriousness of one's symptoms b Persistently high level of anxiety about health or symptoms c Excessive time and energy devoted to these symptoms or health concerns C Although any one somatic symptom may not be continuously present, the state of being symptomatic is persistent (typically more than 6 months) Table 10 . 
Management guidelines
Treatment
Treatment of psychogenic itch can be grouped under three headings: dermatological, psychopharmacological, and psychotherapeutic.
Dermatological management
Traditional dermatological treatments such as creams, lotions, and ointments are generally not effective in managing psychogenic pruritus. However, they could be of great value in reducing any secondary component caused by persistent itch, scratching, and skin manipulation. Repetitive scratching may lead to damage of the epidermis, and moisturizer could be helpful in repairing the skin barrier. Moisturizers also reduce dryness of skin that is a potential aggravating factor in many pruritic conditions. Many commercially available moisturizers with antipruritic properties include menthol, anesthetic agents, capsaicin, and N-palmitoylethanolamine. The cooling and soothing properties of these agents make the patients believe that his or her treatment has started working. Localized areas of skin inflammation respond well to topical steroids or calcineurin inhibitors.
In conditions such as PN or lichen simplex chronicus, occluding the lesions following topical application gives better results. Occlusion not only enhances the effects of topical medication by improving penetration but also physically protects the lesions from further self-inflicted trauma by lack of direct access, reducing the pleasure derived from the process of scratching. 126 
Pharmacological treatment
Several pharmacological agents have been used and have demonstrated success in treating pruritic conditions (Table 11 ).
The choice of agent is based upon the psychopathophysiological nature of the condition. Understanding the particular pathology and the neurotransmitter system that is likely involved may help guide specific therapy to develop a tailored treatment plan.
When the underlying psychopathology is dominated by anxiety, depression, and obsessive-compulsive spectrum disorders, the use of SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin norepinephrine reuptake inhibitors) may be helpful. SSRIs have shown greater efficacy than placebo in several studies. All SSRIs have similar efficacy and mode of action.
The choice is dependent upon underlying medical or dermatological conditions and side effect profile. For example, citalopram and escitalopram have less potential for drug interactions, as compared to paroxetine and fluoxetine, and are thus suitable for patients who are already taking many medications for their concomitant medical conditions. Mirtazapine, an alpha 2 adrenergic and serotonin 5-HT2 antagonist, is particularly useful for nocturnal pruritus owing to its strong sedative properties that can aid in sleep that may be devastated by itch at night.
Besides insomnia, mirtazapine also helps with stimulating appetite and addressing depression. In a case series by Davis et al., 127 four patients reported significant reduction in pruritus associated with mirtazapine therapy. Fluoxetine has also shown positive response in many studies in reducing pruritus. 128 Arnold et al. patients. 131 In a prospective study on 40 patients with biliary cirrhosis, authors concluded that sertraline caused significant reduction or resolution of pruritus. 132 The oral and topical use of doxepin has also been employed in the treatment of pruritus.
Doxepin has very high affinity for H1 receptors compared to hydroxyzine and diphenhydramine. 133 Strong antipruritic effects of doxepin are associated with its high affinity and antagonist action on histamine receptors. In a double-blind crossover study comparing doxepin with diphenhydramine for the treatment of chronic urticaria, authors reported superior efficacy of doxepin over diphenhydramine in patients with urticaria. 134 Doxepin was found to be useful due its ability to effectively suppress the wheal and itch response, along with shortening the duration of the wheal response in cold urticaria. Doxepin was also superior in efficacy compared to other conventional antihistamines such as cinnarizine, cyproheptadine, and hydroxyzine. 135 Antipsychotics are another group of psychiatric medications used in pruritic conditions. They have been used in nonhistamine-induced and psychogenic itch particularly influenced by delusions and psychosis. Sometimes they are augmented with other agents such as SSRIs, SNRIs, or antihistamines to get maximum efficacy in addressing itch with multifactorial underlying pathophysiology. Pimozide, risperidone, olanzapine, and ziprasidone have been used in many pruritic conditions. Pimozide is phenylbutylpiperadine, a potent centrally acting dopamine D2 receptor antagonist. In a double blind crossover study on 11 patients with delusion of parasitosis, pimozide showed significant improvement of delusions along with relief of itch in 6 weeks therapy. 136 Olanzapine has also been successfully used in the treatment of delusion of parasitosis in a case series of three patients. 137 Psychogenic excoriations and self mutilations were successfully treated by olanzapine in a case series of three patients. 138 Pimozide augmentation with ziprasidone pruritus. 148, 149 Gabapentin also secondarily inhibited calcitonin gene-related peptide release and substance P (a mediator of itch). 150 Pregabalin has shown more efficacy than gabapentin in the treatment of fibromyalgia and therefore may be beneficial for patients with functional itch associated with the disease. CBT has been useful in several dermatoses, both pruritic and nonpruritic. 163 Since chronic itch shares many features with chronic pain, psychological interventions that have proved effective in chronic pain should prove successful in the treatment of chronic pruritus as well. Contextual CBT is a type of CBT that has shown positive effects in chronic pain patients. 164 The basics of contextual CBT involve recognition of emotions and behaviors produced by patients' symptoms (pain or itch) in an attempt to help the patient come to terms with his or her symptoms (pain or itch), as opposed to merely controlling them. Ultimately the aim of contextual CBT is to change how patients respond to symptoms as opposed to preventing symptoms. 165 In relation to contextual CBT, two techniques, acceptance and commitment therapy (ACT) and mindfulness-based stress reduction (MBSR), are widely used in the treatment of chronic pain. 166 Acceptance and commitment therapy focuses on strengthening psychological flexibility. This psychological flexibility is related to six core processes. Each of these processes are conceptualized as a positive psychological skill and are overlapping and interrelated as each supports the other and all target psychological flexibility. 167 Recent meta-analyses demonstrate that ACT is at least as effective as more traditional forms of CBT and is efficacious in terms of both acute and longer term effects on symptoms and functioning for a wide variety of conditions including pain, depression, anxiety, and borderline personality disorders. 168 Acceptance is an alternative to experiential avoidance.
Acceptance involves embracing negative disease-related events, emotions, and cognitions to alter the functions of these events and thoughts. For example, patients with pruritus are thought to feel itch and encourage them to let go of a struggle with itch.
Cognitive diffusion is another feature of acceptance and commitment therapy, and this technique attempts to alter the unde- Mindfulness-based stress reduction Mindfulness-based stress reduction was first described by Kabat-Zinn in 1982. 170 It includes practices like meditation, exercises, and yoga. This has been useful and effective in the treatment of chronic pain. 171, 172 Mindfulness involves attending to relevant aspects of experience in a nonjudgmental manner.
The goal of mindfulness is to maintain awareness moment by moment, disregarding oneself from strong attachment to beliefs, thoughts, or emotions and thus developing a greater sense of emotional balance and well-being. 173 MBSR influences susceptibility or ability to recover from disability and disease by decreasing perception of physical symptoms, increasing tolerability of symptoms, reducing anxiety, stress, and depression, increasing motivation for lifestyle changes, increasing interpersonal relationships and social connectedness, and alteration of biological pathways affecting health. A randomized clinical trial by Kabat-Zinn et al. 174 showed that patients with moderate to severe psoriasis who were meditating guided by meditation tapes, while undergoing UVB or PUVA treatments, cleared at about four times the rate of subjects who received the UVB or PUVA alone.
Relaxation training
Relaxation training has been deemed helpful in many conditions characterized by stress, tension, and anxiety. Many itch conditions have also responded well to relaxation techniques. 175, 176 Relaxation techniques lower heart rate, decrease stress, and increase level of self-reported relaxation. 177 Two major relaxation techniques demonstrating reduction in itch include progressive muscle relaxation and autogenic training.
Progressive muscle relaxation, originally described by Edmund Jacobson in the beginning of the 20th century, is characterized by progressive tension and subsequent relaxation of muscles. Throughout the session, the patient visualizes the muscle tensing and a wave of relaxation flowing over them as the tension is released. A Korean study led by Bae et al.
176
found progressive muscle relaxation a useful adjunctive 
